AI-driven MRI biomarker for triple-class HER2 expression classification in breast cancer: a large-scale multicenter study. Wong C, Yang Q, Liang Y, Wei Z, et al. Breast Cancer Res 2025;27:166.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wong C, Yang Q, Liang Y, Wei Z, et al. AI-driven MRI biomarker for triple-class HER2 expression classification in breast cancer: a large-scale multicenter study. Breast Cancer Res 2025;27:166.
PMID: 41013591